Found: 9
Select item for more details and to access through your institution.
Phase I study of S-1 plus paclitaxel combination therapy as a first-line treatment in elderly patients with advanced non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 2, p. 291, doi. 10.1007/s10637-018-0656-z
- By:
- Publication type:
- Article
Variability of serum CYFRA 21 − 1 and its susceptibility to clinical characteristics in individuals without cancer: a 4-year retrospective analysis.
- Published in:
- BMC Pulmonary Medicine, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12890-023-02650-x
- By:
- Publication type:
- Article
Measurement of exhaled nitric oxide and serum surfactant protein D levels for monitoring radiation pneumonitis following thoracic radiotherapy.
- Published in:
- Oncology Letters, 2017, v. 14, n. 4, p. 4190, doi. 10.3892/ol.2017.6691
- By:
- Publication type:
- Article
Phase II Study of S‐1 and Paclitaxel Combination Therapy in Patients with Previously Treated Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 8, p. 1033, doi. 10.1634/theoncologist.2019-0290
- By:
- Publication type:
- Article
A Phase II Study of S‐1 and Paclitaxel Combination Therapy as a First‐Line Treatment in Elderly Patients with Advanced Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 459, doi. 10.1634/theoncologist.2018-0858
- By:
- Publication type:
- Article
Phase II Trial of Weekly Gemcitabine and Split-dose Cisplatin for Advanced Non-small-cell Lung Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2009, v. 39, n. 12, p. 779, doi. 10.1093/jjco/hyp111
- By:
- Publication type:
- Article
Intrapleural Pirarubicin (4′-O-Tetrahydropyranyladriamycin) for Treatment of Malignant Pleural Effusion.
- Published in:
- Japanese Journal of Clinical Oncology, 1996, v. 26, n. 5, p. 328, doi. 10.1093/oxfordjournals.jjco.a023241
- By:
- Publication type:
- Article
Phase I/II trial of biweekly docetaxel and cisplatin with concurrent thoracic radiation for stage III non-small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 6, p. 735, doi. 10.1007/s00280-006-0220-y
- By:
- Publication type:
- Article
Age and Smoking Status Affect Serum Cytokeratin 19 Fragment Levels in Individuals Without Cancer.
- Published in:
- In Vivo, 2022, v. 36, n. 5, p. 2297, doi. 10.21873/invivo.12959
- By:
- Publication type:
- Article